|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print January 30, 2002
Am J Physiol Cell Physiol, 10.1152/ajpcell.00424.2001
Submitted on September 4, 2001
Accepted on January 29, 2002
1 Geriatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA
2 Anatomy and Neurobiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
3 Geriatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Central Arkansas Veterans Health Care System, Little Rock, AR, USA
* To whom correspondence should be addressed. E-mail: dupontesthere{at}uams.edu.
In this study, the role of the calcineurin pathway in skeletal muscle atrophy and atrophy-reducing interventions was investigated in rat soleus muscles. Since calcineurin has been suggested to be involved in skeletal and cardiac muscle hypertrophy, we hypothesized that blocking calcineurin activity would eliminate beneficial effects of interventions that maintain muscle mass in the face of atrophy-inducing stimuli. Hind limb suspension and spinal cord transection were used to induce atrophy and intermittent reloading and exercise, respectively, were used to reduce atrophy. Cyclosporine (CsA) was administered at 25 mg/kg/day to block calcineurin activity. Soleus muscles were studied 14 days after the onset of atrophy. CsA administration did not inhibit the beneficial effects of the two muscle-maintaining interventions nor did it change muscle mass in control or atrophied muscles, suggesting that calcineurin does not play a role in regulating muscle size during atrophy. However, calcineurin abundance was increased in atrophied soleus muscles and this was associated with nuclear localization of NFATc1. Therefore, results suggest that calcineurin may be playing opposing roles during skeletal muscle atrophy and under muscle mass maintaining conditions.
This article has been cited by other articles:
![]() |
E. E. Dupont-Versteegden, R. Nagarajan, M. L. Beggs, E. D. Bearden, P. M. Simpson, and C. A. Peterson Identification of cold-shock protein RBM3 as a possible regulator of skeletal muscle size through expression profiling Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1263 - R1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Adams, F. Haddad, P. W. Bodell, P. D. Tran, and K. M. Baldwin Combined isometric, concentric, and eccentric resistance exercise prevents unloading-induced muscle atrophy in rats J Appl Physiol, November 1, 2007; 103(5): 1644 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Dupont-Versteegden, B. A. Strotman, C. M. Gurley, D. Gaddy, M. Knox, J. D. Fluckey, and C. A. Peterson Nuclear translocation of EndoG at the initiation of disuse muscle atrophy and apoptosis is specific to myonuclei Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1730 - R1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Dupont-Versteegden, J. D. Fluckey, M. Knox, D. Gaddy, and C. A. Peterson Effect of flywheel-based resistance exercise on processes contributing to muscle atrophy during unloading in adult rats J Appl Physiol, July 1, 2006; 101(1): 202 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Fluckey, M. Knox, L. Smith, E. E. Dupont-Versteegden, D. Gaddy, P. A. Tesch, and C. A. Peterson Insulin-facilitated increase of muscle protein synthesis after resistance exercise involves a MAP kinase pathway Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1205 - E1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sugiura, N. Abe, M. Nagano, K. Goto, K. Sakuma, H. Naito, T. Yoshioka, and S. K. Powers Changes in PKB/Akt and calcineurin signaling during recovery in atrophied soleus muscle induced by unloading Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1273 - R1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Leeuwenburgh, C. M. Gurley, B. A. Strotman, and E. E. Dupont-Versteegden Age-related differences in apoptosis with disuse atrophy in soleus muscle Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1288 - R1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Gallegly, N. A. Turesky, B. A. Strotman, C. M. Gurley, C. A. Peterson, and E. E. Dupont-Versteegden Satellite cell regulation of muscle mass is altered at old age J Appl Physiol, September 1, 2004; 97(3): 1082 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Parsons, D. P. Millay, B. J. Wilkins, O. F. Bueno, G. L. Tsika, J. R. Neilson, C. M. Liberatore, K. E. Yutzey, G. R. Crabtree, R. W. Tsika, et al. Genetic Loss of Calcineurin Blocks Mechanical Overload-induced Skeletal Muscle Fiber Type Switching but Not Hypertrophy J. Biol. Chem., June 18, 2004; 279(25): 26192 - 26200. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Parsons, B. J. Wilkins, O. F. Bueno, and J. D. Molkentin Altered Skeletal Muscle Phenotypes in Calcineurin A{alpha} and A{beta} Gene-Targeted Mice Mol. Cell. Biol., June 15, 2003; 23(12): 4331 - 4343. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |